Senator Wendy Davis honored by JWV Post 755
Jewish War Veterans Post 755 will honor Senator Wendy Davis at 10 a.m. on Sunday June 13 at Congregation Beth El with an award for her legislative efforts on behalf of all veterans.
The event will include an instillation of officers, a talk by Senator Davis, a silent auction to help the group fund its many charitable works for veterans and a breakfast prepared by Congregation Beth El Brotherhood. Admission is free and all veterans, whether they served in peace or war, are welcome together with their wives or significant others.
Talented artists to highlight TCU piano festival
Dr. Tamás Ungar, executive director of TCU’s Piano Texas International Academy & Festival, tells the TJP that there will be some amazing Jewish talent at this year’s festival. Lilya Zilberstein, one the most sought after pianists in Europe, is making a rare visit to the United States and will be performing at 7:30 p.m on Saturday, June 12 at the Pepsico Recital Hall on the TCU campus. Alexander Kobrin, winner of the 2005 Cliburn Competition, will be featured in a recital at 3 p.m. on Sunday, June 27. Finally, Yoheved Kaplinsky, from Juilliard School, is one of the festival’s most important guest teachers. Tickets are $25. Discounts are available for seniors, music teachers and students. To purchase tickets visit www.pianotexas.org or call 817-257-7456.
Dr. Howard S. Hochster takes on new roles at Yale Cancer Center and Smilow Cancer Center
Howard S. Hochster, MD has recently been appointed professor of medicine in medical oncology, medical director of gastrointestinal oncology, and associate director of clinical research at Yale Cancer Center. Hochster joins Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven from New York University School of Medicine and the NYU Cancer Institute.
“Dr. Hochster’s clinical and leadership experience and national reputation in gastrointestinal oncology will greatly benefit patients at Smilow Cancer Hospital. In addition to his clinical responsibilities, I am grateful to have his expertise in the role of associate director of clinical research as we continue to increase clinical trial opportunities for our patients,” said Dr. Thomas J. Lynch, Jr., Director of Yale Cancer Center and Physician-in-Chief of Smilow Cancer Hospital at Yale-New Haven.
Hochster concentrates his clinical research on the study of new treatments, and combinations of therapies, for patients with advanced and relapsed colorectal cancer. He has been a leader in translational research in development of targeted agents for GI cancers, and expects to continue and expand this work at Yale Cancer Center. He has led national, pivotal clinical trials in the use of Bevacizumab and Cetuximab in colorectal cancer, and maintenance Rituximab for the treatment of low-grade lymphoma.
Previously, he was professor of medicine at New York University School of Medicine in the divisions of Medical Oncology and Clinical Pharmacology. He has been director of the Gastrointestinal Cancer Program at the NYU Cancer Institute and served as director of the NYUCI Clinical Trials Office for six years. He has also served as the principal investigator for the Eastern Cooperative Oncology Group (ECOG) at NYU for the last 16 years.
Hochster is a fellow of the American College of Physicians and a member of the American Society for Internal Medicine, American Society for Clinical Oncology (ASCO), and American Association for Cancer Research. He is the chair of the colorectal cancer track for the 2010 ASCO annual meeting. He currently serves on an NIH study section as a permanent member. He also serves as the associate editor for the journal Gastrointestinal Oncology, and on the editorial board of Current Colorectal Cancer Reports and has served as ad hoc reviewer for every major oncology journal.
Hochster was president of the New York Cancer Society from 2004-2006. He is active in numerous charitable efforts, including director of the Chemotherapy Foundation and a scientific advisor to the Israel Cancer Research Foundation. He is a board member of Team Continuum, which raises funds for assistance to cancer patients through marathons and triathlons.
Hochster graduated from the Yale University with BS and MS degrees in chemistry and received his medical degree from Yale School of Medicine. He completed his residency in internal medicine at New York University – Bellevue Hospital and his fellowship in medical oncology and hematology at New York University Medical Center. He was subsequently awarded a Fulbright Fellowship and worked at the Jules Bordet Cancer Institute in Brussels, Belgium to study clinical pharmacology and early clinical drug development.
Hochster expects to be available for patient consultation and oncologic care at the Yale Cancer Center in July.
Yale Cancer Center is one of a select network of 40 comprehensive cancer centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Yale-New Haven Hospital and the Yale University School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.
Dr. Hochster is the son of former ourtowner Hanna Hochster and the late Martin Hochster.
We would like to hear from our readers! Send all your news to email@example.com.